New Era of Radiosurgery Launches at Penn State Health Milton S. Hershey Medical Center: Installation of Gamma Knife Icon

As technologies and techniques have advanced in recent years, Gamma Knife radiosurgery has become a vital tool for enhancing outcomes among patients with brain tumors and other complex neurological disorders. Penn State Health Milton S. Hershey Medical Center recently reaffirmed its long-standing commitment to provide the most advanced care in the region by upgrading to the latest iteration of the Gamma Knife radiosurgery system: Leksell Gamma Knife® Icon™.

Penn State Cancer Institute: Pioneering Research Unites with Advanced Care in Central Pennsylvania

ESTABLISHED IN 2000, Penn State Cancer Institute, recognized as an American College of Surgeons Commission on Cancer-accredited facility, has evolved into a premier academic oncology center that encompasses clinical care, research, education and outreach. Since 2009, the 178,000-square-foot facility on the Milton S. Hershey Medical Center campus has served as the hub for nearly 160 clinicians, researchers and faculty members based in Hershey and University Park, State College in Centre County. The Cancer Institute care teams see nearly 2,000 individual cases annually.

3-D Printing Takes Pediatric Cardiology and Cardiac Surgery to the Next Level

At Penn State Children’s Hospital, the use of 3-D printing to create models of complex heart anatomy provides an effective tool for enhancing surgical outcomes.

Taking the Lead in Transoral Robotic Surgery

With a commitment to continually upgrading its capabilities to provide optimal patient care, Penn State Health Milton S. Hershey Medical Center has become a pioneer in the use of robotic technology for surgical procedures of the head and neck.

PinnacleHealth CardioVascular Institute Furthers Research into Innovative Cardiovascular Devices

In May of 2013, PinnacleHealth embarked on an exciting journey in caring for patients with blocked heart arteries when it began participating in a three-year clinical trial for the first-of-its-kind drug-eluting Absorb Bioresorbable Vascular Scaffold (BVS).